Comorbidity, Use of Common Medications, and Risk of Early Death in Patients with Localized or Locally Advanced Prostate Cancer
In this paper, we analyze predictive factors for early death from comorbidity (defined as death within 3 years from diagnosis and unrelated to prostate cancer) in patients with localized or locally advanced prostate cancer. Such information may guide individually tailored treatment or observation st...
Saved in:
| Main Authors: | Carsten Nieder, Astrid Dalhaug, Adam Pawinski, Gro Aandahl, Jan Norum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2011.121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
by: Carsten Nieder, et al.
Published: (2012-01-01) -
A Case of Recurrent Breast Cancer with Solitary Metastasis to the Urinary Bladder
by: Carsten Nieder, et al.
Published: (2014-01-01) -
The role of radiotherapy in localised and locally advanced prostate cancer
by: Michel Bolla, et al.
Published: (2019-04-01) -
The Role of Pelvic Exenteration in the Management of Locally Advanced Prostate Cancer
by: Ala'a Farkouh, et al.
Published: (2022-05-01) -
Contribution of adverse events to death of hospitalised patients
by: Ellinor Christin Haukland, et al.
Published: (2019-01-01)